Is esophageal pH monitoring used appropriately in an open-access system? A prospective multicenter study

American Journal of Gastroenterology

Volumn 99, Issue 11, 2004, Pages 2115-2120

  Radaelli, Franco ^a   Strocchi, Enrico ^b   Passaretti, Sandro ^b   Strada, Elena ^b   Frego, Roberto ^b   Dinelli, Marco ^b   Fossati, Daniela ^b   Barzaghi, Franco ^b   Limido, Eugenio ^b   Bortoli, Aurora ^b   Della Casa, Domenico ^b   Missale, Guido ^b   Snider, Licia ^b   Noris, Roberto ^b   Viviani, Giovanni ^b   Minoli, Giorgio ^b  

^a VALDUCE HOSPITAL   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

STOMACH SECRETION INHIBITOR;

ADULT; AGED; AMBULATORY MONITORING; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOSCOPY; ESOPHAGITIS; ESOPHAGUS PH; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH CARE ACCESS; HEALTH CARE SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MULTICENTER STUDY; PATIENT MONITORING; PATIENT REFERRAL; PH MEASUREMENT; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ESOPHAGUS; FEMALE; GUIDELINE ADHERENCE; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MANOMETRY; MIDDLE AGED; MONITORING, AMBULATORY; PATIENT SELECTION; PRACTICE GUIDELINES; REFERRAL AND CONSULTATION;

EID: 8744309167     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.40175.x     Document Type: Article

References (35)

1. Johnson LF, DeMeester TR. Twenty-four hour pH monitoring of the distal esophagus: A quantitative measure of gastroesophageal reflux. Am J Gastroenterol 1974;62:325-32.
2. Ricther JE. Ambulatory esophageal pH monitoring. Am J Med 1997;103:1308-1348.
3. Sarani B, Gleiber M, Evans SR. Esophageal pH monitoring, indications, and methods. J Clin Gastroenterol 2002;34:200-6.
4. Fuchs K, DeMeester TR, Albertucci M. Specificity and sensitivity of objective diagnosis of gastroesophageal reflux disease. Surgery 1987;102:575-80.
5. Younes Z, Johnson DA. Diagnostic evaluation in gastroesophageal reflux disease. Gastroenterol Clin North Am 1999;28:809-30.
6. Martinez SD, Malagon IB, Garewal HS, et al. Non-erosive reflux disease (NERD)-Acid reflux and symptom patterns. Aliment Pharmacol Ther 2003;7:537-45.
7. Johnsson F, Hatlebakk JG, Klintenberg AC, et al. One-week esomeprazole treatment: An effective confirmatory test in patients with suspected gastroesophageal reflux disease. Scand J Gastroenterol 2003;38:354-59.
8. Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, et al. Omeprazole as a diagnostic tool in gastroesophageal reflux disease. Am J Gastroenterol 1997;92:1997-2000.
9. Juul-Hansen P, Rydning A, Jacobsen CD, et al. High-dose proton-pump inhibitors as a diagnostic test of gastrooesophageal reflux disease in endoscopic-negative patients. Scand J Gastroenterol 2001;36:806-10.
10. Pass R, Ofman JJ, Sampliner RE, et al. The omeprazole test is as sensitive as 24-h oesophageal pH monitoring in diagnosing gastro-oesophageal reflux disease in symptomatic patients with erosive oesophagitis. Aliment Pharmacol Ther 2000;14:389-96.
11. Fass R, Fennerty MB, Ofman JJ, et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology 1998;115:42-9.
12. Ours TM, Kavuru MS, Schilz RJ, et al. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am J Gastroenterol 1999;94:3131-8.
13. Metz DC, Childs ML, Ruiz C, et al. Pilot study of the oral omeprazole test for reflux laryngitis. Otolaryngol Head Neck Surg 1997;116:41-6.
14. Wo JM, Grist WJ, Gussack G, et al. Empiric trial of high-dose omeprazole in patients with posterior laryngitis: A prospective study. Am J Gastroenterol 1997;92:2160-5.
15. Bate CM, Riley SA, Chapman RW, et al. Evaluation of omeprazole as a cost-effective diagnostic test for gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1999;13:59-66.
16. Borzecki AM, Pedrosa MC, Prashker MJ. Should noncardiac chest pain be treated empirically? A cost-effectiveness analysis. Arch Intern Med 2000;160:844-52.
17. Pass R, Ofman JJ, Gralnek IM, et al. Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease. Arch Intern Med 1999;159:2161-8.
18. Ofman JJ, Gralnek IM, Udani J, et al. The cost-effectiveness of the omeprazole test in patients with noncardiac chest pain. Am J Med 1999;107:219-27.
19. Dent J, Brun J, Fendrick AM, et al. An evidence-based appraisal of reflux disease management-The Genval Workshop Report. Gut 1999;44(Suppl 2):S1-16.
20. American Gastroenterological Association medical position statement. Guidelines on the use of esophageal pH recording. Gastroenterology 1996;110:1981-96.
21. Baldi F, Crotta S, Penagini R. Guidelines for the diagnostic and therapeutic management of patients with gastrooesophageal reflux disease. A position statement of The Italian Association of Hospital Gastroenterologists (AIGO), Italian Society of Gastrointestinal Endoscopy (SIED), and Italian Society of Gastroenterology (SIGE). Ital J Gastroenterol Hepatol 1998;30:107-12.
22. Dent J. The role of the specialist in the diagnosis and short and long-term care of patients with gastroesophageal reflux disease. Am J Gastroenterol 2001;96(Suppl):S22-S26.
23. Eckardt VF, Dilling B, Bernhard G. The impact of open-access 24-h pH-metry on the diagnosis and management of esophageal reflux disease. Am J Gastroenterol 1999;94:616-21.
24. Vaezi MF, Hicks DM, Abelson TI, et al. Laryngeal signs and symptoms and gastroesophageal reflux disease: A critical assessment of cause and effect association. Clin Gastroenterol Hepatol 2003;1:333-44.
25. Pace F, Annese V, Ceccatelli P, et al. Oesophageal pH-metry. Position paper of the Working Team on Oesophageal pH-metry by the GISMAD (Gruppo Italiano di Studio sulla Motilita dell'Apparato Digerente). Dig Liver Dis 2000;32:357-64.
26. Baldi F, Ferrarini F, Longanesi A, et al. Ambulatory 24-hour oesophageal pH monitoring in normal subjects: A multicentre study in Italy. GISMAD-GOR Study Group. Ital J Gastroenterol 1991;23:477-80.
27. Colletti RB, Christie DL, Orenstein SR. Statement of the North American Society for Pediatric Gastroenterology and Nutrition. Indications for pediatric esophageal pH monitoring. J Pediatr Gastroenterol Nutr 1995;21:253-62.
28. Waring JP. Nonerosive reflux disease. Semin Gastrointest Dis 2001;12:33-7.
29. Shi G, Bruley des Varannes S, Scarpignato C, et al. Reflux related symptoms in patients with normal esophageal exposure to acid. Gut 1995;37:457-64.
30. Quigley EM. 24-h pH monitoring for gastroesophageal reflux disease: Already standard but not yet gold? Am J Gastroenterol 1992;87:1071-5.
31. De Vault KR, Castell DO, and the Practice Parameters Committee of The American College of Gastroenterology. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 1999;94:1434-41.
32. Richter JE. Extraesophageal presentations of gastroesophageal reflux disease: An overview. Am J Gastroenterol 2000;95(Suppl):S1-S3.
33. Pass R. Empirical trials in treatment of gastroesophageal reflux disease. Dig Dis 2000;18:20-6.
34. Richter JE. Medical management of patients with esophageal or supraesophageal gastroesophageal reflux disease. Am J Med 2003;115(Suppl 3A):S179-S187.
35. De Vault KR. Overview of therapy for the extraesophageal manifestations of gastroesophageal reflux disease. Am J Gastroenterol 2000;95(Suppl):S39-S43.